 | ||||||
| in | ||||||
| NEWS | ||||||
| Celgene in discussions to buy Juno Therapeutics Celgene, the acquisitive drugmaker, is in talks with Juno Therapeutics about buying the developer of cutting-edge cancer treatments in what would be its second big deal of 2018. With the acquisition of Juno, Celgene would enter the pioneering field of chimeric antigen receptor therapy (Car-T), which ...
| ||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
ShareThis
No comments:
Post a Comment